| Autor: |
Christian Moser, Petra Ruemmele, Sebastian Gehmert, Hedwig Schenk, Marina P Kreutz, Maria E Mycielska, Christina Hackl, Alexander Kroemer, Andreas A Schnitzbauer, Oliver Stoeltzing, Hans J Schlitt, Edward K Geissler, Sven A Lang |
| Jazyk: |
angličtina |
| Rok vydání: |
2012 |
| Předmět: |
|
| Zdroj: |
Neoplasia: An International Journal for Oncology Research, Vol 14, Iss 10, Pp 915-925 (2012) |
| Druh dokumentu: |
article |
| ISSN: |
1476-5586 |
| DOI: |
10.1593/neo.12878 |
| Popis: |
The prognosis of patients suffering from pancreatic cancer is still poor and novel therapeutic options are urgently needed. Recently, the transcription factor signal transducer and activator of transcription 5b (STAT5b) was associated with tumor progression in human solid cancer. Hence, we assessed whether STAT5b might serve as an anticancer target in ductal pancreatic adenocarcinoma (DPAC). We found that nuclear expression of STAT5b can be detected in approximately 50% of DPAC. Blockade of STAT5b by stable shRNA-mediated knockdown showed no effects on tumor cell growth in vitro. However, inhibition of tumor cell motility was found even in response to stimulation with epidermal growth factor or interleukin-6. These findings were paralleled by a reduction of prometastatic and proangiogenic factors in vitro. Subsequent in vivo experiments revealed a strong growth inhibition on STAT5b blockade in subcutaneous and orthotopic models. These findings were paralleled by impaired tumor angiogenesis in vivo. In contrast to the subcutaneous model, the orthotopic model revealed a strong reduction of tumor cell proliferation that emphasizes the meaning of assessing targets in an appropriate microenvironment. Taken together, our results suggest that STAT5b might be a potential novel target for human DPAC. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
